Mice deficient in sphingosine 1-phosphate receptor type 2 (S1P 2 ) develop diffuse large B cell lymphoma. However, the role of S1P 2 in normal germinal center (GC) physiology is unknown. Here we show that S1P 2 -deficient GC B cells outgrew their wild-type counterparts in chronically established GCs. We found that antagonism of the kinase Akt mediated by S1P 2 and its downstream mediators Ga 12 , Ga 13 and p115RhoGEF regulated cell viability and was required for growth control in chronically proliferating GCs. Moreover, S1P 2 inhibited GC B cell responses to follicular chemoattractants and helped confine cells to the GC. In addition, S1P 2 overexpression promoted the centering of activated B cells in the follicle. We suggest that by inhibiting Akt activation and migration, S1P 2 helps restrict GC B cell survival and localization to an S1P-low niche at the follicle center.
Germinal centers (GCs) are induced in response to T cell-dependent antigens and support events necessary for antibody affinity maturation 1, 2 . They arise in the center of B cell follicles and grow from small numbers of starting B cells to a size of ~1 × 10 4 cells in a matter of days. Despite such rapid growth, GC size is tightly regulated, even in mesenteric lymph nodes (mLNs) and Peyer's patches, in which the responses are chronically stimulated by gut flora 3 . Apoptosis is an integral part of GC growth control, as GC B cells are highly prone to apoptotic death and are very dependent on the ligand for the costimulatory molecule CD40 and other trophic factors 4 . These factors act at least in part by maintaining expression of proteins of the antiapoptotic Bcl-2 family, including Mcl-1, that are critical for GC formation 5 . However, despite knowledge of key requirements for the maintenance of GC cell viability, the environmental cues involved in regulating GC size are not fully understood.
GCs are organized into dark and light zones by the chemokines CXCL12 and CXCL13, respectively 6 . CXCL13 is present throughout the follicle and in the GC light zone; CXCL12 is present in the dark zone 6 . Despite the important roles of these chemokines, combined deficiency in the function of their receptors does not cause complete loss of GC formation 6 . Another chemoattractant receptor, EBI2, is upregulated in early activated (pre-GC) B cells and functions in guiding these cells to the outer follicle 7, 8 . EBI2 is downregulated in GC B cells, a change that is important for access of GC B cells to the follicle center 7 . However, in the absence of EBI2, GCs form in their normal location, which indicates that additional cues must act to promote clustering of GC precursors at the follicle center.
Sphingosine 1-phosphate (S1P) is a metabolic intermediate made by all eukaryotic cell types during sphingolipid metabolism through the action of sphingosine kinase 1 (Sphk1) and Sphk2 (ref. 9) . S1P is secreted by some cell types. The extracellular lipid acts as a ligand for any of the following five G protein-coupled receptors: S1P 1 -S1P 5 (ref. 9 ). Extracellular S1P is abundant in blood and lymph (high nanomolar to micromolar concentrations) but has a half-life shorter than 15 minutes (ref. 10) , and although no direct measurements of interstitial concentrations have been reported, indirect measurements indicate they are very low 11, 12 . Red blood cells and endothelial cells are important sources of circulatory S1P 10, 12, 13 . Two S1P phosphatases, three lipid phosphate phosphatases and S1P lyase can degrade S1P, and catabolism has a critical role in maintaining the low interstitial concentrations of S1P 14 . S1P promotes the egress of lymphocytes from lymphoid tissue into circulatory fluids. Whether sufficient amounts of interstitial S1P exist in the lymphoid parenchyma to regulate cell activity has remained unclear.
In this study we set out to define the molecular cues involved in the regulation of GC size and GC B cell clustering. We found that S1P 2 was expressed by GC B cells and was necessary to maintain control of the size of chronically stimulated GCs. S1P 2 and its downstream mediators Gα 12 , Gα 13 and p115RhoGEF antagonized signaling by the kinase Akt and cell viability. S1P 2 also inhibited the chemotaxis of GC B cells toward follicular chemoattractants and helped to promote the confinement of GC B cells to the GC. In addition, overexpression of S1P 2 in non-GC B cells promoted their localization to the follicle center. On the basis of our results, we propose a model in which S1P signals through S1P 2 to regulate the survival and positioning of GC B cells, thus promoting GC homeostasis through dual roles.
RESULTS
Uncontrolled growth of S1P 2 -deficient GCs Genome-wide comparison of gene expression in follicular and GC B cells identified S1pr2 (which encodes S1P 2 ) as one of the genes most strongly induced in GC B cells 15 (data not shown), and we confirmed this difference in expression by quantitative RT-PCR ( Fig. 1a) . When we immunized 8-to 12-week-old S1P 2 -deficient mice 16 with T cell-dependent antigens, they seemed to mount GC responses of normal magnitude. However, 1-year-old S1P 2 -deficient mice showed population expansion of GC B cells in mLNs ( Fig. 1b) as well as more total B cells and T cells. In about half the mice, GC B cell numbers reached as much as 100 times the normal amount, and the architecture of the lymph node was effaced ( Fig. 1b,c) . We speculate that the bimodality of GC expansion in these mice was due to cooperation between S1P 2 deficiency and secondary genetic events, resulting in loss of GC homeostasis and development of GC-type lymphoma. Similar observations have been made with another S1P 2 -deficient mouse line, and the outgrowths were classified as diffuse large B cell lymphoma 17 . These results demonstrate a requirement for S1P 2 in maintaining GC B cell homeostasis.
Growth advantage of S1P 2 -deficient cells in chronic GCs
To determine if the requirement for S1P 2 in GC B cell homeostasis was cell intrinsic, we studied mixed-bone marrow chimeras. In mice reconstituted with a mixture of S1P 2 -deficient (S1pr2 −/− ) and wild-type bone marrow at a ratio of ~1:2, S1P 2 -deficient GC B cells over-accumulated relative to their wild-type counterparts in mLNs, whereas follicular B cells were present in proportion to the bone marrow chimerism (Fig. 1d,e and Supplementary Fig. 1 ). The outgrowth was even more evident in mice reconstituted with a mixture of S1pr2 −/− and wildtype bone marrow at a ratio of ~1:9 and was evident in both mLNs and Peyer's patches ( Fig. 1f) . We not observe such outgrowth in the spleens of chimeric mice immunized intraperitoneally with sheep red blood cells (SRBCs) to induce splenic GCs at day 8 after immunization ( Fig. 1e ,f) or in splenic or mLN GCs induced 14 d after immunization with nitrophenol-chicken γ-globulin ( Supplementary Fig. 1 ). However, we noted gradual outgrowth of S1P 2 -deficient GC B cells in the endogenous splenic response of unimmunized mixed-bone marrow chimeras ( Supplementary Fig. 1 ). This suggested that the outgrowth may have depended on the long-term persistence of the GCs rather than on unique properties of mucosal tissues. The advantage for S1P 2deficient cells was dependent on S1P derived from radiation-resistant cells, as it was lower in polyinosinic-polycytidylic acid-treated hosts heterozygous for a loxP-flanked allele encoding Sphk1 and expressing Cre recombinase from Mx1 (Sphk1 f/− Mx1-Cre) and also deficient in Sphk2 (Sphk2 −/− ); these mice lack Sphk2 and are broadly deficient for Sphk1 in cells responsive to interferon-α and interferon-β ( Fig. 1g) . S1P 2 can couple to Gα 12 and Gα 13 (ref. 18) . To assess the role of these Gα proteins in GC B cells, we generated mice deficient in the gene encoding Gα 12 and intercrossed them with mice homozygous for loxP-flanked alleles encoding Gα 13 (ref. 19) and carrying the Mx1-Cre transgene. We used mice treated for the induction of Cre expression as a source of bone marrow cells doubly deficient in Gα 12 and Gα 13 . In mice reconstituted with a mixture of wild-type and Gα 12 -Gα 13 -deficient bone marrow, follicular B cells reflected the Spleen mLN
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S1pr2 S1pr1 Figure 1 Growth advantage of GC B cells deficient in S1P 2 , Gα 12 -Gα 13 or p115RhoGEF in chronic GCs. (a) Quantitative PCR analysis of the transcript abundance of S1pr1 and S1pr2 in follicular (FO) and GC B cells, presented relative to the abundance of Hprt1 (encoding hypoxanthine guanine phosphoribosyl transferase). (b,c) GC B cells in spleen and mLNs (b) and immunohistochemical staining of mLNs (c) from 1-year-old S1pr2 +/− and S1pr2 −/− mice. Scale bar (c), 500 µm. A r t i c l e s bone marrow chimerism 20 , whereas there was outgrowth of Gα 12 -Gα 13 -deficient B cells in mucosal GCs (Fig. 1h) . These observations suggest a selective role for Gα 12 and Gα 13 in mediating S1P 2 signals in GC B cells. The small GC B cell accumulation seen at day 8 in splenic responses to SRBCs was similar in the control (Gα 12 -deficient) and Gα 12 -Gα 13 -deficient groups and may have reflected an effect of Gα 12 single deficiency or influences of genes from the 129 background. A major effector pathway of Gα 12 -Gα 13 in lymphocytes is activation of p115RhoGEF (encoded by Arhgef1), which leads to activation of the small GTPase Rho [21] [22] [23] . At 8-12 weeks after reconstitution with wild-type and Arhgef1 −/− bone marrow, p115RhoGEF-deficient GC B cells outgrew wild-type cells, although in this case the advantage was not focused in mucosal sites ( Fig. 1i and Supplementary Fig. 1) . These observations suggest that S1P 2 signals through Gα 12 -Gα 13 and Rho to maintain B cell homeostasis in chronically stimulated GCs.
Regulation of the survival of GC B cells by S1P 2
The rate of proliferation was similar for S1P 2 -deficient and wild-type GC B cells, as assessed by the incorporation of the thymidine analog bromodeoxyuridine 0.5 and 6 h after a single injection of bromodeoxyuridine ( Supplementary Fig. 2) . In contrast, the rate of apoptotic cell death was lower for S1P 2 -deficient cells ( Fig. 2a,b and Supplementary  Fig. 2 ) and Gα 12 -Gα 13 -deficient cells ( Supplementary Fig. 2) , assessed ex vivo by measurement of active caspase-3 and DNA fragmentation. Because S1P 2 and Rho are suggested to negatively regulate Akt in some contexts [24] [25] [26] [27] , we sought to determine whether the activity of this prosurvival kinase was altered in the absence of S1P 2 . Intracellular flow cytometry analysis of Akt phosphorylated at Thr308 showed that S1P 2 -deficient GC B cells had more active kinase than did control GC B cells isolated from the same mixed-bone marrow chimeras ( Fig. 2c) . We observed a similarly greater abundance of Akt phosphorylated at Thr308 in wild-type GC B cells incubated for 30 min with the S1P 2 antagonist JTE-013 ( Fig. 2d ) and when we added JTE-013 to the medium we used to prepare the cell suspensions ( Supplementary Fig. 2) . We prepared and incubated cells in the absence of added S1P; thus, cells had bound sufficient ligand in vivo or during isolation to promote S1P 2 signaling. Coincubation with the phosphatidylinositol-3-OH kinase inhibitor wortmannin prevented the increase in phosphorylated Akt (Fig. 2d) . The S1P 2 -mediated inhibition of Akt activation was dependent on endogenous S1P, as there was more phosphorylated Akt in GC B cells from Sphk-deficient mice ( Fig. 2e) . GC B cells isolated from Gα 12 -Gα 13 -deficient mice and p115RhoGEF-deficient mice had a similarly greater abundance of phosphorylated Akt (Fig. 2f) .
The propensity of wild-type GC B cells to undergo prompt apoptosis in vitro limits the biochemical measurements that can be made with these cells. To assess the signals downstream of S1P 2 that regulate Akt, we used the human GC B cell line Ramos, which expresses S1P 2 (data not shown). Ramos cells had abundant constitutive phosphorylated Akt, which is not unusual for transformed cell lines (Fig. 2g) . Exposure of these cells to S1P led to less phosphorylated Akt, which was prevented by coincubation with the S1P 2 antagonist JTE-013 ( Fig. 2g) . Treatment with Y27632, an inhibitor of the Rho effector kinase ROCK, prevented S1P from causing the full decrease in phosphorylated Akt (Fig. 2h,i) . ROCK can inhibit Akt by activating PTEN, an inositol phosphatase 28 . However, incubation of cells in the presence of the PTEN inhibitors bpV(pic) ( Fig. 2h) , bpV(phen) or VO-OHpic (data not shown) did not prevent the S1P-mediated down-modulation of phosphorylated Akt (Fig. 2h) . These observations suggest that after GC B cells encounter S1P, S1P 2 acts via activation of Rho and ROCK triggered by Gα 12 -Gα 13 and p115RhoGEF to antagonize Akt activation.
Akt activation confers an advantage to mucosal GCs
To address if more Akt activity was sufficient to give GC B cells a growth advantage, we transduced bone marrow cells with retrovirus encoding constitutively active Akt with a myristoylation signal attached to the amino terminus (myr-Akt) 29 or control retrovirus and used these cells to reconstitute wild-type mice. Stem cells with the myr-Akt construct were inefficient at generating follicular B cells, but the mLN GC compartment showed enrichment for cells expressing myr-Akt (Supplementary Fig. 3 ). In mice that received bone marrow cells transgenic for expression of Cre driven by the gene encoding CD21 (complement receptor 2; Cr2-Cre) and transduced with retrovirus encoding a version of the myr-Akt construct modified before the initiator ATG with a cassette of loxP site-stop sequence-loxP site (followed by an internal ribosomal entry site and a CD90.1 (Thy-1.1) reporter), which results in expression of myr-Akt restricted to mature B cells, reconstitution of follicular B cells was more successful. GCs of mucosal lymphoid tissues were enriched for cells expressing myr-Akt (Fig. 3a) , and GC B cells expressing myr-Akt had a lower rate of apoptotic death (Fig. 3b) . These results suggest that more Akt activation is sufficient to confer a growth advantage on GC B cells.
Akt can promote cell viability by many pathways, including phosphorylation and inhibition of the proapoptotic molecule Bad, inhibition of Foxo transcription factors that induce proapoptotic molecules such as Bim, and phosphorylation and inhibition of the translationinitiation inhibitor 4E-BP1, which lead to small increases in capdependent translation of many proteins, including some prosurvival molecules 30 . Analysis of mice reconstituted with a mixture of wildtype and Bad-deficient bone marrow did not demonstrate a growth advantage for Bad-deficient GC B cells (Supplementary Fig. 3) , and gene-expression analysis of sorted wild-type and S1P 2 -deficient GC B cells failed to demonstrate differences in the expression of Foxo target genes such as the gene encoding Bim (Supplementary Fig. 3) . Intracellular staining showed that S1P 2 -deficient GC B cells had a greater abundance of phosphorylated 4E-BP1 ( Fig. 3c) . To directly assess whether loss of S1P 2 signaling promoted translation in GC-type B cells, we measured the incorporation of 35 S-labeled cysteine and methionine in Ramos GC B cells. In the absence of S1P, or in the presence of the S1P 2 antagonist JTE-013, there was more incorporation of 35 S-labeled cysteine and methionine by Ramos cells (Fig. 3d) . The translation inhibitory effect of S1P 2 signaling was similar in magnitude to that achieved by rapamycin, an inhibitor of the kinase mTOR (Fig. 3d) . These findings suggest that S1P 2 signaling in GC B cells normally suppresses Akt and thus mTOR activity, leading to less phosphorylation of 4E-BP1 and less cap-dependent translation, which may affect the translation of many prosurvival molecules 30 . The coupling of S1P 2 to Rho activation is associated with inhibition of the migration of many cell types 31, 32 . To assess the effect of S1P 2 on the migration of GC B cells toward follicular chemoattractants, we intercrossed S1P 2 -deficient mice with Bcl2-transgenic mice to overcome the rapid in vitro death of GC B cells 6 . Nanomolar concentrations of S1P inhibited the migration of GC B cells, but not of follicular B cells, toward CXCL13 and CXCL12 in a manner that was reversed by coincubation with the S1P 2 antagonist JTE-013 ( Fig. 4a) .
We confirmed the selective action of S1P via S1P 2 in inhibiting the migration of GC B cells by using S1P 2 -deficient GC B cells (Fig. 4b) .
Although GCs continued to form in their normal location in the absence of S1P 2 , the boundary between the GC and mantle zone was often less well defined ( Fig. 4c and Supplementary Fig. 4) . In mixed-bone marrow chimeras, S1P 2 -deficient cells were segregated from wild-type cells and there was enrichment for these cells at or beyond the GC perimeter (Supplementary Fig. 5 ). The segregation was largely reversed in Sphk-deficient hosts (Supplementary Fig. 5 ). Gα 12 -Gα 13 -deficient GC B cells showed a similar tendency to segregate from wild-type GC B cells (Supplementary Fig. 5 ).
For dynamic analysis of S1P 2 -deficient GC B cell activity in the context of wild-type GCs, we transferred S1P 2 -deficient Hy10 B cells (specific for hen egg lysozyme) and OT-II T cells (specific for ovalbumin) into wild-type hosts that we then immunized with the lowaffinity antigen complex of duck egg lysozyme-ovalbumin to induce GC responses 33 . In frozen sections, S1P 2 -deficient Hy10 B cells were concentrated at the GC perimeter, often seeming to intermingle with follicular mantle cells with high expression of immunoglobulin D (IgD hi ; Fig. 4d ). Two-photon microscopy of explanted lymph nodes containing S1P 2 -deficient Hy10 B cells positive for green fluorescent protein and wild-type Hy10 B cells positive for cyan fluorescent protein showed the movement of many more S1P 2 -deficient GC B cells than wild-type GC B cells beyond the confines of the GC, as identified by the location of immune complex-laden follicular Videos 1-3) . The S1P 2deficient GC B cells moved at higher velocities and with less turning than did the wild-type GC B cells ( Fig. 4e and Supplementary  Fig. 6) . As a result, they traveled in straighter paths ( Fig. 4f and  Supplementary Fig. 6 ). When we defined the GC surface on the basis of the distribution of naive B cells ( Fig. 4g, Supplementary Fig. 6 and Supplementary Videos 4-6) , it became apparent that S1P 2 -deficient GC B cells had similar velocities and turning angles whether located outside or inside the GC surface (Fig. 4g,h and Supplementary  Fig. 6) . In contrast, wild-type GC B cells had a lower velocity and more turning when outside the GC surface (Fig. 4g,h and Supplementary  Fig. 6) . These observations suggest that as GC B cells move beyond the confines of the GC, they receive S1P 2 -mediated signals that inhibit their migration and prompt their turning.
dendritic cells (FDCs; Supplementary
Despite the considerable alteration in the distribution of S1P 2 -deficient cells in the context of a predominantly wild-type GC, we did not observe effects on affinity maturation (Supplementary Fig. 7) . This suggests that under the immunization conditions used here, S1P 2 -deficient cells continued to gain adequate access to antigen and helper T cells. This does not exclude the possibility that during the response to some antigen types, S1P 2 -deficient cells will show defects in affinity maturation.
Promotion of GC cell clustering by S1P 2
GCs continue to form in S1P 2 -deficient mice, and although S1P 2deficient cells extend beyond the normal GC boundary, they do not disperse freely throughout the follicle, which suggests that additional cues promote their GC association. Although the nature of these cues remains undefined, we considered the possibility that the removal of general follicle-organizing factors might produce a hypomorphic state that could better demonstrate the confining activity of S1P 2 . CXCL13 was abundant in the follicle and GC light zone, and SRBC-immunized CXCL13-deficient mice had smaller, less organized GCs than those of wild-type mice but did retain these structures 6 (Fig. 5a) . S1P 2 -deficient GC B cells failed to form GC clusters in immunized CXCL13-deficient hosts (Fig. 5a) . Instead, GC B cells with high expression of the GC marker GL7 were dispersed throughout the lymphoid areas (Fig. 5a) . In another approach, we pretreated mice for 3 weeks with an antagonist of lymphotoxin-α 1 β 2 to disrupt follicular stromal cell networks 34 before immunizing the mice with SRBCs. This treatment also led to more dispersal of S1P 2 -deficient GC B cells than of wild-type GC B cells (Fig. 5b) . These data suggest that when GC organization is compromised by removal of CXCL13 or alteration of follicular stromal cells, S1P 2 has a nonredundant role in promoting the clustering of GC B cells. They also establish that S1P 2 promotes such clustering by a mechanism beyond inhibition of the CXCL13 response.
Regulation of S1P by B cells
The interstitial S1P concentrations in the lymphoid tissues are lower than the high concentrations in circulatory fluids but are not precisely defined and may vary among various parts of the tissue 9, 35, 36 . Although it is not possible to directly measure interstitial S1P, the extent of S1P 1 down-modulation from the surface of cells has provided an indirect measure 11, 12 . According to the staining with a monoclonal antibody to mouse S1P 1 , wild-type follicular B cells had S1P 1 expression intermediate between that of blood B cells (exposed to micromolar concentrations of S1P 9 ) and B cells from S1P-deficient mice (Fig. 6a) . By comparison with the amount of S1P needed to cause partial down-modulation of S1P 1 in lymphocytes in vitro 11 , it can be approximated that the follicle contains interstitial S1P in the low nanomolar range. These concentrations are sufficient to result in less migration of S1P 2 -expressing cells toward chemokines (Fig. 4a) .
Analysis of the abundance of transcripts encoding S1P-degrading enzymes showed that B cells expressed most of the enzymes that degrade extracellular S1P and, relative to the amounts in T cells, they had especially large amounts of transcripts encoding the lipid phosphate phosphatases LPP2 and LPP3 (Fig. 6b) , which have active sites in the extracellular region 14 . Incubation of S1P with purified B cells or T cells led to rapid degradation of the lipid by B cells (Fig. 6c) . Because the source of extracellular S1P seemed to be radiation resistant and thus was probably stromal cells ( Fig. 1g) , we next sought to determine whether FDCs, the main radiation-resistant cell type present in the center of follicles and in GCs, were a necessary source of S1P. Deletion of Sphk1 (in Sphk2-deficient mice) in FDCs through the use of Cr2-Cre did not prevent the growth advantage of S1P 2 -deficient mLN GC B cells, and S1P 2 -deficient cells remained segregated from wild-type GC B cells (Supplementary Fig. 5 ). This indicated that FDCs are not a required source of S1P for the mediation of S1P 2 functions in GC B cells. These findings collectively suggest that extracellular S1P derives from stromal cells outside the follicle center and that it is rapidly degraded as it travels through the follicle, which led us to propose that interstitial S1P concentrations are lowest in the follicle center.
S1P 2 directs B cells to the follicle center
If our hypothesis about the distribution of S1P were correct, cells expressing S1P 2 might be antagonized in their migration toward chemoattractants in the outer follicle. Thus, S1P 2 expression should favor migration toward the center of the follicle (Supplementary Fig. 8) .
To test this possibility, we examined the distribution of transferred S1P 2expressing B cells in GC-containing follicles (Fig. 7a) . Transduction of B cells with S1P 2 led to more clustering of those B cells around GCs than of B cells transduced with control vector (Fig. 7a) . S1P 2 overexpression was also sufficient to cause occasional clustering of the a b CXCL13-deficient host S1pr2 -/-S1pr2 + A r t i c l e s transferred cells in the center of primary follicles (that lacked GCs), but this result was more variable. B cell activation, required for retroviral transduction of B cells, results in upregulation of EBI2 (encoded by Gpr183), a receptor that guides B cells to the outer follicle 8 . We considered the possibility that more EBI2 function might favor movement of the transduced B cells to the outer follicle and thus counteract the effect of S1P 2 expression. Gpr183 +/− B cells expressed about half as much Gpr183 as wild-type B cells did (Supplementary Fig. 5 ). Transferred S1pr2-transduced Gpr183 +/− B cells showed a considerable bias for migration to the follicle center ( Fig. 7b) . Notably, vector-transduced Gpr183 +/− cells did not show any bias in their distribution (Fig. 7b) , which demonstrated that being heterozygous for Gpr183 was not sufficient to cause a centering effect. Transfer of S1P 2 -expressing cells into hosts broadly deficient in Sphk proteins did not result in a distribution bias (Fig. 7c) , which indicated that S1P was the signal required. However, we still observed the bias in hosts that selectively lacked Sphk proteins in FDCs (Supplementary Fig. 5 ). These observations suggest that upregulation of S1P 2 favors the movement of cells to the follicle center, probably as a consequence of the low concentrations of S1P in this area (Supplementary Fig. 8 ). Although we consider it less likely, our results do not exclude the possibility that S1P 2 -overexpressing cells 'preferentially' die in the outer follicle rather than the center follicle as a result of differences in exposure to S1P.
DISCUSSION
Here we have demonstrated that S1P 2 has a dual role in GC B cells, regulating survival and promoting clustering at the follicle center. We have provided evidence that S1P 2 acted through a signaling module involving Gα 12 -Gα 13 and p115RhoGEF as well as, most probably, Rho and ROCK to dampen Akt activation in GC B cells. We suggest that when S1P 2 was absent, more Akt activity led to more phosphorylation of 4E-BP1, a modification that released this inhibitor from eIF4E, allowing small increases in cap-dependent translation of a range of transripts 37 . The inhibitor 4E-BP1 regulates the translation of transcripts with complex 5′ untranslated regions, including those for many prosurvival molecules [38] [39] [40] . Our data do not exclude the possibility that Akt promotes the survival of GC B cells through additional pathways, such as regulation of the kinase GSK3 or the glucose transporter Glut1 (ref. 41) . S1P 2 can signal via Akt-independent pathways 31, 32 , and it is possible that less signaling through such pathways also contributes to the growth advantage of S1P 2 -deficient cells. Although our ex vivo analysis suggested a considerable prosurvival effect of S1P 2 deficiency, the in vivo advantage became evident only over a periods of weeks in chronically stimulated GCs. This suggests that the contribution of S1P 2 is relatively small during acute antigendriven GC responses, whereas it is greater under the conditions associated with cell isolation. This may be a consequence of the exposure of GC B cells to the higher concentrations of S1P present outside the GC during tissue preparation as well as the stresses of in vitro culture. We suggest that the contribution of S1P 2 in vivo may become c b (a) Surface abundance of S1P 1 on follicular B cells from the peripheral lymph nodes (pLN), blood and spleens of wild-type control mice (Ctrl), S1pr1-deficient mice (S1P1-KO) and Sphk1 f/− Mx1-CreSphk2 −/− or Sphk1 f/f Mx1-CreSphk2 −/− mice (S1P-deficient). (b) Abundance of transcripts encoding S1P lyase (Sgpl1), sphingosine 1-phosphate phosphatase 1 (Sgpp1) and lipid phosphate phosphatases (Lpp1-Lpp3) in B cells and T cells, presented relative to Hprt1 transcript abundance. (c) S1P remaining in culture supernatants before (S1P alone) and after (S1P +) incubation for 30-180 min (horizontal axis) with B cells or T cells, assessed as staining of Flag-tagged S1P1 and presented relative to results of reporter cells not exposed to S1P (No S1P). Data are representative of three experiments with more than three mice of each type (a) or two experiments (b) or are from three experiments (c). most evident under conditions of greater genotoxic stress that arise because of chronic GC stimulation at mucosal sites. The survival advantage may increase the likelihood that cells acquire and survive secondary oncogenic hits, thereby setting the stage for progression to diffuse large B cell lymphoma. The G protein G q negatively regulates the activation of Akt in naive B cells 42 , which indicates that many G protein-coupled receptors exert a controlling influence over Akt activation in B cells. B cells with more Akt activity because of PTEN deficiency or Akt overexpression are reported to have less isotype switching as a result of less function of the cytidine deaminase AID 43, 44 . We did not observe defects in isotype switching or affinity maturation in S1P 2 -deficient Hy10 B cells, which suggested that AID function was intact. These differences may reflect the fact that the increase in Akt activity is less in S1P 2 -deficient B cells than in PTEN-deficient B cells, or they may indicate differences in the way distinct pools of activated Akt are integrated into downstream signaling networks 45 . S1P has a well-established role in promoting the egress of lymphocytes from lymphoid tissues 9, 12 . Our findings here have established that S1P also has a role in regulating cell activity in lymphoid tissue. Follicular S1P is derived from radiation-resistant cells other than FDCs and is rapidly degraded by B cells. S1P has a half-life in plasma shorter than 15 minutes (ref. 10) . Given that the most abundant cells in blood (red blood cells) do not express S1P-degrading enzymes 9 , whereas B cells do, it seems likely that the half-life of S1P in densely packed B cell follicles is at least this short.
We propose a model in which S1P concentrations are relatively high in the outer follicle and 'decay' to a low concentration over the FDC network at the follicle center. We suggest that the induction of S1P 2 in GC precursor cells, by inhibiting their propensity to migrate toward CXCL13 and other attractants in the S1P hi outer follicle, helps to focus the cells to the follicle center. S1P 2 may also act by promoting chemorepulsion 46 , though we have not found that GC B cells move away from S1P in Transwell migration assays. Downregulation of EBI2 is also important in allowing GC cells to move away from the outer follicle 7 . Once a GC forms, S1P in this microenvironment may be kept in low concentrations by local degradation and by minimal carriage of S1P into the structure by newly arriving cells. When an S1P 2expressing GC B cell reaches the GC perimeter, it probably encounters higher concentrations of S1P, which causes activation of Rho at the leading edge, prompting the retraction of cellular processes 47 and cell turning. Because S1P 2 signaling also causes Akt inhibition, this growth-regulatory effect may be greatest in GC B cells migrating near the GC perimeter. Thus, through dual growth-regulatory and migrationinhibitory activities, S1P 2 may act as one of many factors that help link GC size to the volume of the supportive niche at the follicle center. Future studies should develop techniques for measuring interstitial S1P concentrations to provide a better understanding of how S1P 2 could control both processes. Nevertheless, we feel it reasonable to suggest, on the basis of the existing data, that a general property of Gα 12 -Gα 13 -coupled receptors may be to help coordinate niche confinement and cell survival.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
